The Medicine Maker | The Medicine Maker

George Tidmarsh: FDA Resignation and Lawsuit

November 5, 2025

Tidmarsh reportedly resigns from FDA and Aurinia Pharmaceuticals files lawsuit

2 min read

From the Apollo Era to the World's First Cell Therapy: Sitting Down With Bruce Levine

Bruce Levine shares his journey from a childhood steeped in science to co-founding the first CAR T-cell trials, and explains why communication and regulatory collaboration are crucial for the field’s future.

Outsourcing

Why ‘Good Enough’ is Not Acceptable in CRO Partnerships

Clinical trials are becoming more complex. And not all CROs are able to step up.

Business & Trends

Supply Chains and the Next Black Swan Event

Are pharma logistics and supply chains ready for the next test?

Interviews

Overcoming the Static Sales Cycle

For decades, pharma sales strategies have been built on static lists and old data. Now, AI-driven models are replacing guesswork with live insights

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Christine Allen

Professor, University of Toronto; Co-founder and CEO, Intrepid Labs

View Profile

Hanns-Christian Mahler

CEO (Chief Enablement Officer) & Board Member, ten23 health

View Profile

FOYA: Celebrating Innovation in Pharma Facilities

We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.

Read the article

All the latest Medicine Maker articles.

Cell & Gene

Roving Reporter Asks: What’s Your Tech Wishlist in CGT?

November 3, 2025

IBTV interviews 3 experts from the 2025 Cell & Gene Therapy Summit in London about advances in technology.

Cell & Gene Interviews Technology & Manufacturing

How To Optimize Batch Release for Advanced Therapies

November 3, 2025

For advanced therapies, every hour counts. The pressure on QA and QC teams is intense. How can automation ease the strain?

4 min read

Industry News Small Molecules Regulation & Standards

Securing Europe’s Antibiotic Supply: A More Functional Future

October 31, 2025

The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.

3 min read

Industry News Small Molecules

Texas Takes on Tylenol

October 31, 2025

Texas Attorney General is suing Tylenol manufacturers, alleging misleading safety concerns and links with autism.

2 min read

Industry News Small Molecules

Summarizing the Big Events in the Small Molecules Field

October 30, 2025

October 2025 highlights in the small molecules sector include developments in dermatitis treatment, improvements in epilepsy symptoms, and the effects of amoxicillin availability.

4 min read

Cell & Gene Facilities & Equipment Technology & Manufacturing Interviews

Rise of the Robots: Scaling Up Cell Therapies in Small Spaces

October 29, 2025

Manual processes in cell therapy manufacturing are unsustainable. Bring in the robots.

3 min read

Industry News

CPHI 2025: AI, the Pharma Workforce, and Reshaping Investment

October 29, 2025

Day 3 of our special show coverage of CPHI Frankfurt

2 min read

Cell & Gene

Cell and Gene Therapy: Hope, Hype and Political Upheaval

October 29, 2025

The cell and gene field has come a long way since the 1970s, but does political upheaval threaten progress?

1 min read

Industry News Biopharma

This Week’s Biopharma News: Novo Nordisk Board Shakeup

October 28, 2025

This week’s news roundup reports on the boardroom reshuffle at Novo Nordisk, Novartis’ neuromuscular expansion, GSK’s Global Fund pledge and more.

4 min read

Industry News

Get Ready for Day 2 of CPHI 2025: Sustainability Power Hour

October 28, 2025

We select highlights from the show’s agenda

3 min read

Top Stories